Statement of Use

SYMJEPI

Adamis Pharmaceuticals Corporation

Trademark/Service Mark Statement of Use

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1553 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)

Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88162331
LAW OFFICE ASSIGNED LAW OFFICE 118
EXTENSION OF USE NO
MARK SECTION
MARK http://uspto.report/TM/88162331/mark.png
LITERAL ELEMENT SYMJEPI
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size or color.
OWNER SECTION
NAME Adamis Pharmaceuticals Corporation
STREET 11682 El Camino Real, Suite 300
CITY San Diego
STATE California
ZIP/POSTAL CODE 92130
COUNTRY United States
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Injectable solution of epinephrine for treating allergic reactions; Prefilled syringe for injecting an epinephrine solution
GOODS OR SERVICES KEEP ALL LISTED
FIRST USE ANYWHERE DATE 12/00/2018
FIRST USE IN COMMERCE DATE 12/00/2018
SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPN0-205149289-20190624154101461815_._SYMJEPI_-_Specimen.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT17\IMAGEOUT17\881\623\88162331\xml9\SOU0002.JPG
SPECIMEN DESCRIPTION photograph of goods and packaging
REQUEST TO DIVIDE NO
PAYMENT SECTION
NUMBER OF CLASSES IN USE 1
SUBTOTAL AMOUNT [ALLEGATION OF USE FEE] 100
TOTAL AMOUNT 100
SIGNATURE SECTION
DECLARATION SIGNATURE /David J Marguglio/
SIGNATORY'S NAME David J. Marguglio
SIGNATORY'S POSITION Senior Vice President/Chief Business Officer
DATE SIGNED 06/25/2019
SIGNATORY'S PHONE NUMBER 858-412-7950
FILING INFORMATION
SUBMIT DATE Wed Jun 26 12:18:20 EDT 2019
TEAS STAMP USPTO/SOU-XXX.XXX.XX.X-20
190626121820895340-881623
31-6201f81774185eb3eea826
7df4fe4eb6db27d92cdfca96a
f446f6a626ba96ae99-DA-155
39-20190624154101461815



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1553 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)


Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:
MARK: SYMJEPI(Standard Characters, see http://uspto.report/TM/88162331/mark.png)
SERIAL NUMBER: 88162331



The applicant, Adamis Pharmaceuticals Corporation, having an address of
      11682 El Camino Real, Suite 300
      San Diego, California 92130
      United States
is submitting the following allegation of use information:

For International Class 005:
Current identification: Injectable solution of epinephrine for treating allergic reactions; Prefilled syringe for injecting an epinephrine solution

The mark is in use in commerce on or in connection with all of the goods/services, or to indicate membership in the collective organization listed in the application or Notice of Allowance or as subsequently modified for this specific class.

The mark was first used by the applicant, or the applicant's related company, licensee, or predecessor in interest at least as early as 12/00/2018, and first used in commerce at least as early as 12/00/2018, and is now in use in such commerce. The applicant is submitting one specimen for the class showing the mark as used in commerce on or in connection with any item in the class, consisting of a(n) photograph of goods and packaging.

Original PDF file:
SPN0-205149289-20190624154101461815_._SYMJEPI_-_Specimen.pdf
Converted PDF file(s) (1 page)
Specimen File1


The applicant is not filing a Request to Divide with this Allegation of Use form.
A fee payment in the amount of $100 will be submitted with the form, representing payment for the allegation of use for 1 class.


Declaration


The signatory believes that the applicant is the owner of the mark sought to be registered.
For a trademark or service mark application, the mark is in use in commerce on or in connection with all the goods/services in the application or notice of allowance, or as subsequently modified.
For a collective trademark, collective service mark, collective membership mark application, the applicant is exercising legitimate control over the use of the mark in commerce by members on or in connection with all the goods/services/collective membership organization in the application or notice of allowance, or as subsequently modified.
For a certification mark application, the applicant is exercising legitimate control over the use of the mark in commerce by authorized users on or in connection with the all goods/services in the application or notice of allowance, or as subsequently modified, and the applicant is not engaged in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.
The specimen(s) shows the mark as used on or in connection with the goods/services/collective membership organization in commerce.
To the best of the signatory's knowledge and belief, no other persons, except, if applicable, authorized users, members, and/or concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.



Signature: /David J Marguglio/      Date Signed: 06/25/2019
Signatory's Name: David J. Marguglio
Signatory's Position: Senior Vice President/Chief Business Officer
Signatory's Phone: 858-412-7950

RAM Sale Number: 88162331
RAM Accounting Date: 06/26/2019

Serial Number: 88162331
Internet Transmission Date: Wed Jun 26 12:18:20 EDT 2019
TEAS Stamp: USPTO/SOU-XXX.XXX.XX.X-20190626121820895
340-88162331-6201f81774185eb3eea8267df4f
e4eb6db27d92cdfca96af446f6a626ba96ae99-D
A-15539-20190624154101461815



Statement of Use [image/jpeg]

Statement of Use [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed